SEARCH

SEARCH BY CITATION

References

  • 1
    Halliwell R. Revised nomenclature for veterinary allergy. Veterinary Immunology and Immunopathology 2006; 114: 20078.
  • 2
    Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy. Veterinary Immunology and Immunopathology 2001; 81: 3116.
  • 3
    Griffin CE, Hillier A. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Veterinary Immunology and Immunopathology 2001; 81: 36384.
  • 4
    Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy. Veterinary Immunology and Immunopathology 2001; 81: 31722.
  • 5
    DeBoer DJ, Griffin CE. The ACVD task force on canine atopic dermatitis (XXI): antihistamine pharmacotherapy. Veterinary Immunology and Immunopathology 2001; 81: 32330.
  • 6
    Olivry T, Marsella R, Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective? Veterinary Immunology and Immunopathology 2001; 81: 34762.
  • 7
    Marsella R, Olivry T. The ACVD task force on canine atopic dermatitis (XXII): nonsteroidal anti-inflammatory pharmacotherapy. Veterinary Immunology and Immunopathology 2001; 81: 33145.
  • 8
    Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 2003; 14: 12146.
  • 9
    Jüni P, Altman DG, Egger M. Systematic reviews in health care – assessing the quality of controlled clinical trials. British Medical Journal 2001; 323: 426.
  • 10
    Oxman A, Guyatt G, Cook D et al. Summarizing the evidence. In: GuyattG, RennieD, eds. Users’ Guides to the Medical Literature – Essentials of Evidence-Based Medicine. Chicago, IL: AMA Press, 2002: 24169.
  • 11
    Willemse T. Atopic skin disease: a review and a reconsideration of diagnostic criteria. Journal of Small Animal Practice 1986; 27: 7718.
  • 12
    Prélaud P, Guaguère E, Alhaidari Z et al. Réévaluation des critères de diagnostic de la dermite atopique [Reevaluation of diagnostic criteria of atopic dermatitis]. Revue De Médecine Vétérinaire 1998; 149: 105764.
  • 13
    DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001; 81: 2716.
  • 14
    Griffin CE, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001; 81: 25569.
  • 15
    Bettenay S. A double-blind trial evaluating homeopathic drops in the treatment of atopy in 20 dogs (abstract). In: KwochkaKW, WillemseT, Von TscharnerC, eds. Advances in Veterinary Dermatology, Vol. 3. Oxford, UK: Butterworth-Heinemann, 1998: 5089.
  • 16
    Logas D, Kunkle GA. Double-blinded crossover study with marine oil supplementation containing high-dose eicosapentaenoic acid for the treatment of canine pruritic skin disease. Veterinary Dermatology 1994; 5: 99104.
  • 17
    DeBoer DJ, Schafer JH, Salsbury CS et al. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus. American Journal of Veterinary Research 2002; 63: 40813.
  • 18
    Nesbitt GH, Freeman LM, Hannah SS. Effect of n-3 fatty acid ratio and dose on clinical manifestations, plasma fatty acids and inflammatory mediators in dogs with pruritus. Veterinary Dermatology 2003; 14: 6774.
  • 19
    Dodman NH, Shuster L, Nesbitt G et al. The use of dextromethorphan to treat repetitive self-directed scratching, biting, or chewing in dogs with allergic dermatitis. Journal of Veterinary Pharmacology and Therapeutics 2004; 27: 99104.
  • 20
    Marsella R, Nicklin CF. Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. Veterinary Dermatology 2002; 13: 20310.
  • 21
    Steffan J, Parks C, Seewald W et al. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis. Journal of the American Veterinary Medical Association 2005; 226: 185563.
  • 22
    Willemse A, Van Den Brom WE, Rijnberg A. Effect of hyposensitization on atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 1984; 184: 127780.
  • 23
    Ewert G, Daems T. Traitement de la dermite atopique canine par un copolymere d’acides gras: Une etude clinique comparative en double aveugle [Treatment of canine atopic dermatitis by a fatty acid copolymer: comparative double blind study]. Pratique Médicale et Chirurgicale de l’Animal de Compagnie 2001; 36: 4018.
  • 24
    Olivry T, Steffan J, Fisch RD et al. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 2002; 221: 3707.
  • 25
    Bensignor E. Usefulness of one hypoallergenic diet in the management of atopic dermatitis in dogs (abstract). Veterinary Dermatology 2002; 14: 261.
  • 26
    Olivry T, Rivierre C, Murphy KM et al. Maintenance treatment of canine atopic dermatitis with cyclosporine: Decreasing dosages or increasing intervals? (abstract). Veterinary Dermatology 2003; 14: 220.
  • 27
    Iwasaki T, Hasegawa A. A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic dogs using antihistamine as control. Veterinary Dermatology 2006; 17: 195200.
  • 28
    Thelen A, Mueller R, Linek M. Administration of cyclosporine with food does not influence the clinical response in atopic dogs. Veterinary Record 2006; 159: 8546.
  • 29
    Crow DW, Marsella R, Nicklin CF. Double-blinded, placebo-controlled, cross-over pilot study on the efficacy of zileuton for canine atopic dermatitis. Veterinary Dermatology 2001; 12: 18995.
  • 30
    Marsella R, Nicklin CF, Melloy C. The effects of capsaicin topical therapy in dogs with atopic dermatitis: A randomized, double-blinded, placebo-controlled, cross-over clinical trial. Veterinary Dermatology 2002; 13: 1319.
  • 31
    Olivry T, Rivierre C, Jackson HA et al. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: A blinded randomized prednisolone-controlled trial. Veterinary Dermatology 2002; 13: 7787.
  • 32
    Harvey RG. A blinded, placebo-controlled study of the efficacy of borage seed oil and fish oil in the management of canine atopy. Veterinary Record 1999; 144: 4057.
  • 33
    Nagle TM, Torres SM, Horne KL et al. A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis. Veterinary Dermatology 2001; 12: 26574.
  • 34
    Noli C, Carta G, Cordeddu L et al. Conjugated linoleic acid and black currant seed oil in the treatment of canine atopic dermatitis: a preliminary report. Veterinary Journal 2007; 173: 41321.
  • 35
    Paradis M, Scott DW, Giroux D. Further investigations on the use of nonsteroidal and steroidal antiinflammatory agents in the management of canine pruritus. Journal of the American Animal Hospital Association 1991; 27: 448.
  • 36
    Ferrer L, Alberola J, Queralt M et al. Clinical anti-inflammatory efficacy of arofylline. a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Veterinary Record 1999; 145: 1914.
  • 37
    Steffan J, Alexander D, Brovedani F et al. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel blinded randomized controlled trial. Veterinary Dermatology 2003; 14: 1122.
  • 38
    Rème CA, Lloyd DH, Burrows A et al. Anti-allergic shampoo and oral essential fatty acid combination therapy to relieve signs of canine atopic dermatitis: a blinded, prednisolone-controlled trial (abstract). Veterinary Dermatology 2005; 14: 355.
  • 39
    Marsella R, Nicklin CF, Saglio S et al. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Veterinary Dermatology 2004; 15: 294303.
  • 40
    Bensignor E, Olivry T. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. Veterinary Dermatology 2005; 16: 5260.
  • 41
    Scott DW, Miller WH, Decker GA et al. Failure of cyproheptadine hydrochloride as an antipruritic agent in allergic dogs: results of a double-blinded, placebo-controlled study. Cornell Veterinarian 1992; 82: 24751.
  • 42
    Paterson S. Use of antihistamines to control pruritus in atopic dogs. Journal of Small Animal Practice 1994; 35: 4159.
  • 43
    Scott DW, Miller WH, Cayatte SM et al. Failure of terfenadine as an antipruritic agent in atopic dogs – results of a double-blinded, placebo-controlled study. Canadian Veterinary Journal - Revue Vétérinaire Canadienne 1994; 35: 2868.
  • 44
    Paradis M. Nonsteroidal antipruritic drugs in dogs and cats: an update. Bulletin of the Canadian Academy of Veterinary Dermatology 1996; 37.
  • 45
    DeBoer DJ, Moriello KA, Pollet RA. Inability of a short duration treatment with a lipoxygenase inhibitor to reduce clinical signs of canine atopy. Veterinary Dermatology 1994; 5: 136.
  • 46
    Marsella R, Nicklin CF. Double-blinded cross-over study on the efficacy of pentoxifylline for canine atopy. Veterinary Dermatology 2000; 11: 25560.
  • 47
    Colombo S, Hill PB, Shaw DJ et al. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study. Veterinary Dermatology 2005; 16: 16270.
  • 48
    Mueller RS, Fieseler KV, Zabel S et al. Conventional and rush allergen-specific immunotherapy in the treatment of canine atopic dermatitis. In: HillierA, FosterAP, KwochkaKW, eds. Advances in Veterinary Dermatology, Vol. 5. Oxford, UK: Blackwell Publishing, 2005: 609.
  • 49
    Ricklin Gutzwiller ME, Reist M, Peel JE et al. Intradermal injection of heat-killed Mycobacterium vaccae in dogs with atopic dermatitis: a multicentre pilot study. Veterinary Dermatology 2007; 18: 8793.
  • 50
    Bond R, Lloyd DH. A double-blind comparison of olive oil and a combination of evening primrose oil and fish oil in the management of canine atopy. Veterinary Record 1992; 131: 55860.
  • 51
    Bond R, Lloyd DH. Randomized single-blind parallel comparison of an evening primrose oil and fish oil combination and concentrates of these oils in the management of canine atopy. Veterinary Dermatology 1992; 3: 2159.
  • 52
    Scarff DH, Lloyd DH. Double blind, placebo-controlled, crossover study of evening primrose oil in the treatment of canine atopy. Veterinary Record 1992; 13: 979.
  • 53
    Scott DW, Miller WH, Decker GA et al. Comparison of the clinical efficacy of two commercial fatty acid supplements (efavet and DVM DermCaps), evening primrose oil, and cold water marine fish oil in the management of allergic pruritus in dogs: a double-blinded study. Cornell Veterinarian 1992; 82: 31929.
  • 54
    Bond R, Lloyd DH. Double-blind comparison of three concentrated essential fatty acid supplements in the management of canine atopy. Veterinary Dermatology 1993; 4: 1859.
  • 55
    Paterson S. Additive benefits of EFAs in dogs with atopic dermatitis after partial response to antihistamine therapy. Journal of Small Animal Practice 1995; 36: 38994.
  • 56
    Sture GH, Lloyd DH. Canine atopic disease – therapeutic use of an evening primrose oil and fish-oil combination. Veterinary Record 1995; 137: 16970.
  • 57
    Noli C, Scarampella F. Efficacia dell’olio di semi di ribes nero nella dermatite atoica del cane: Uno studio in doppio cieco controllato da placebo [Efficacy of blackcurrant seed oil in canine atopic dermatitis: a double blind placebo controlled study]. Veterinaria Cremona 2002; 16: 5560.
  • 58
    Mueller RS, Fieseler KV, Fettman MJ et al. Effect of omega-3 fatty acids on canine atopic dermatitis. Journal of Small Animal Practice 2004; 45: 2937.
  • 59
    Saevik BK, Bergvall K, Holm BR et al. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology 2004; 15: 13745.
  • 60
    Campbell KL, Mardini A, Rème CA et al. Efficacy of an essential fatty acid supplement to reduce clinical signs of atopic dermatitis in dogs and to change serum fatty acid levels: a double-blinded placebo-controlled cross-over study (abstract). Veterinary Dermatology 2005; 16: 356.
  • 61
    Baddaky-Taugbøl B, Vroom MW, Nordberg L et al. A randomized, controlled, double-blinded, multicentre study on the efficacy of a diet rich in fish oil and borage oil in the control of canine atopic dermatitis. In: HillierA, FosterAP, KwochkaKW, eds. Advances in Veterinary Dermatology, Vol. 5. Oxford, UK: Blackwell Publishing, 2005: 17387.
  • 62
    Ferguson EA, Littlewood JD, Carlotti DN et al. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study. Veterinary Dermatology 2006; 17: 23643.
  • 63
    DeBoer DJ, Moriello KA, Pollet RA. The efficacy of AHR-13268, an anti-allergenic compound, in the management of pruritus caused by atopic disease in dogs. American Journal of Veterinary Research 1992; 53: 5326.
  • 64
    Olivry T, Dunston SM, Rivierre C et al. A randomized controlled trial of misoprostol monotherapy for canine atopic dermatitis: effects on dermal cellularity and cutaneous tumor necrosis factor-alpha. Veterinary Dermatology 2003; 14: 3746.
  • 65
    Olivry T, Marsella R, Iwasaki T et al. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Veterinary Dermatology 2007; 18: 7996.
  • 66
    De Vos C, Maleux MR, Baltes E et al. Inhibition of histamine and allergen skin wheal by cetirizine in four animal species. Annals of Allergy 1987; 59: 27882.
  • 67
    Hansson H, Bergvall K, Bondesson U et al. Clinical pharmacology of clemastine in healthy dogs. Veterinary Dermatology 2004; 15: 1528.